SCLX

Scilex Holding Company

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$1.56

Price (1 Year)

$12.68 $1.56

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %51.5 / %30
Non-compliant assets / Total market cap %12.3 / %30
Non-compliant revenue / Total income %54.5 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Website

Analysis (Turkish): SCLX Hissesi Caiz mi, Helal mi? Scilex Holding Company Katılım Analizi